President Trump's order calls for correcting this imbalance. The Republican-backed EPIC Act offers the clearest solution, ...

U.S. Senator Kirsten Gillibrand (D–N.Y.) is backing a bill that she contends would significantly reduce the cost of ...

Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...

After years of political debate and pressure from the pharmaceutical industry, a long-awaited reform has finally materialized ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...

Buying Dividend Aristocrats at bargain prices can be a winning investment strategy. Read about two such stocks that are ...

The Trump administration aims to issue a rule empowering regulators to “forcefully” go after companies that don’t share drug ...

Mehmet Oz recently took the reins as the new head of the Centers for Medicare & Medicaid Services (CMS), which oversees health coverage for nearly half of Americans. He will ...

The Inflation Reduction Act includes an exemption for orphan drugs for a single indication, but experts say this is far from ...

Americans pay disproportionately to subsidize pharmaceutical innovation, while the rest of the world benefits and pays less ...